Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Novo Nordisk’s long-acting haemophilia B drug cleared by FDA

US approval sets up marketing battle with Bioverativ and CSL Behring

- PMLiVE

TogoRun appoints Clare Preskett as co-managing director

She will share duties with Jonathan Kearney who has been promoted

- PMLiVE

M3 appoints Paul Rice as chief operating officer

Simon Walker also joins the online doctor communities group

- PMLiVE

Pfizer wins EU approval for MenB vaccine Trumenba

US pharma firm’s injection can now be given to patients aged 10 and above

- PMLiVE

Gilead plans fightback against HIV arch-rival ViiV

Descovy sees phase III success after the TAF-based drug proves non-inferior to Triumeq

So, you want Uber to take you to the hospital?

Why using ride-sharing services in place of ambulance services is a bad idea

Generation Now: the impact of the millennial HCP on our world

Millennials are criticised as narcissistic, entitled and technology-obsessed, but our new campaign shows millennial healthcare professionals – mHCPs – in a different light. They have certainly grown up in a...

Havas Lynx

Novartis building

Novartis’ Zykadia claims US approval for first-line lung cancer

The Swiss pharma giant’s drug also receives CHMP positive opinion

- PMLiVE

Novo seeks to strengthen Tresiba label in US

Studies find insulin degludec advantage over insulin glargine

Rare diseases: meeting the challenge

Problems with regulating orphan drugs

- PMLiVE

FDA panel backs Puma’s breast cancer drug, with reservations

Side effects concerns could see medicines limited

- PMLiVE

Pfizer gets FDA panel recommendation for biosimilar EPO

Product could be the first direct competitor to Epogen and Procrit in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links